Biosensing refers to the detection and measurement of biological or biochemically relevant targets using biological recognition, chemical interfaces, and physical signal transduction. In nanotechnology, biosensing uses nanomaterials such as graphene, carbon nanotubes, gold nanoparticles, quantum dots, nanowires, magnetic nanoparticles, and plasmonic structures to improve sensitivity, miniaturization, multiplexing, and response time. Biosensing platforms can detect proteins, nucleic acids, metabolites, pathogens, toxins, cells, and biomarkers.
Biosensing matters because it supports diagnostics, health monitoring, environmental testing, food safety, bioprocess control, and research on biological systems. Nanoscale transducers can amplify electrochemical, optical, mechanical, magnetic, or thermal signals while functional surfaces provide selectivity. Key challenges include fouling, calibration, sample preparation, reproducibility, stability, and real-world validation. The field connects closely to biosensors, point-of-care diagnostics, lab-on-chip systems, and surface functionalization.
Conferences on biosensing appear in nanotechnology, biotechnology, analytical chemistry, biomedical engineering, diagnostics, and sensor programs. Sessions often cover wearable biosensors, electrochemical detection, plasmonic sensing, molecular recognition, microfluidics, and clinical translation. Tracking biosensing events helps researchers follow how nanoscale interfaces are turning biological signals into useful measurements.